Related Experiment Video

Updated: Jul 4, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

[Clinical features of mixed infections in patients with Streptococcus pneumoniae pneumonia]

Shunsuke Minagawa1, Noboru Takayanagi, Kenichiro Hara

  • 1Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|June 4, 2008
PubMed

Insights

Mixed infections, including influenza virus and Haemophilus influenzae, are linked to severe Streptococcus pneumoniae pneumonia (SPP). Initial combination antimicrobial therapy showed effectiveness in mild-moderate mixed SPP cases.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Streptococcus pneumoniae pneumonia (SPP) is a common respiratory illness.
  • Mixed infections, involving multiple pathogens, can complicate SPP diagnosis and treatment.
  • Understanding the impact of mixed pathogens on SPP severity and treatment is crucial.

Purpose of the Study:

  • To analyze the severity, mortality, and initial antimicrobial therapy in patients with SPP.
  • To identify common co-pathogens in mixed SPP cases.
  • To evaluate the effectiveness of different antimicrobial strategies in mixed SPP.

Main Methods:

  • Retrospective analysis of 195 patients diagnosed with SPP.
  • Classification of pneumonia severity based on Japanese Respiratory Society criteria.
  • Categorization of initial antimicrobial therapies (beta-Lactam alone, combination, fluoroquinolone alone).

Main Results:

  • 30.3% of SPP patients had mixed infections, frequently involving influenza virus, Haemophilus influenzae, and Mycoplasma pneumoniae.
  • Severe and very severe pneumonia was significantly associated with mixed infections (P = 0.018).
  • Initial combination antimicrobial therapy was significantly effective in mild-moderate mixed SPP.

Conclusions:

  • Mixed infections are a significant factor in SPP severity.
  • Identifying the specific etiology in SPP is essential for optimal treatment.
  • Further research into the role of co-pathogens and tailored antimicrobial strategies is warranted.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...